Vellux 100UI Manufacturer+for sale

Vellux™ is a next-generation botulinum toxin type A developed by AEGEN Bio (South Korea), containing 100 units per vial. With 99.8% pure neurotoxin complex and albumin-free formulation, it demonstrates rapid action onset within 72 hours and lasting effects for 6-8 months. Clinical trials show 92% patient satisfaction in wrinkle reduction and 89% efficacy in hyperhidrosis management. Complies with KFDA and ISO 13485 standards.

• 3D Rapid Effect: Visible improvement from day 3 post-injection, full effect within 14 days
• Precision Formula: Zero animal proteins/albumin. 40% lower diffusion radius than conventional toxins
• Long Duration: 6-8 months efficacy confirmed in 83% of clinical participants
• Multi-Application: Addresses both cosmetic concerns and medical conditions effectively

Contraindications: Pregnancy, neuromuscular disorders, aminoglycoside therapy, hypersensitivity to botulinum toxin

Adverse Effects: Temporary localized weakness, pain at injection site, headache in some patients

Professional Note: Individual results may vary based on anatomy, technique, and physiological factors

• Vellux™ requires prescription and professional administration by qualified practitioners

• Medical applications should follow approved clinical protocols

• Always follow aseptic techniques during preparation and administration

• Monitor for hypersensitivity reactions during initial administration

• Manufacturer not liable for improper storage or administration errors